Completed Psychology & Behaviour Brain & Nervous System

Goal-oriented cognitive rehabilitation in early-stage Alzheimer's disease: multi-centre single-blind randomised controlled trial (GREAT)

In plain English

AI plain-English summary

A 480-person trial is testing whether personalised cognitive rehabilitation can help people in the early stages of dementia achieve goals they set for themselves—like managing finances, cooking a meal, or remembering appointments. This matters because current NHS care for early dementia typically offers medication and general advice, but no structured, individualised programme to help people maintain everyday functioning. The pilot trial suggested that cognitive rehabilitation—where a therapist works with the patient and their carer to devise practical strategies for specific goals—improves performance on those goals compared to usual care. But the pilot was small and short. This larger, multi-centre trial will confirm whether the approach works across different NHS settings and for a broader range of dementia types, including vascular and mixed dementia. If the trial shows clear benefits, the NHS could adopt cognitive rehabilitation as a standard early intervention. That would give thousands of people with dementia a practical tool to stay independent longer, reduce carer strain, and delay the need for more intensive support. The intervention is delivered at home, so it is scalable without requiring new clinic infrastructure.

View original technical description
Design: Multi-centre single-blind RCT comparing cognitive rehabilitation (CR) to treatment as usual (TAU). Outcomes assessed at 3 and 9 months post randomisation. Setting: The study will take place in six centres across the UK, with a part-time therapist and a part-time research assistant appointed at each centre. Participant identification will be undertaken by local research network staff. Participants will be recruited from memory clinics, old age mental health services and GP practices. Assessments will be conducted, and interventions delivered, in participants’ own homes, with a carer involved where possible. Target population: People with an ICD-10 diagnosis of Alzheimer’s disease (AD), vascular or mixed dementia. For each participant, a carer (a family member or close friend who is either co-resident or in regular contact) will also be involved. Inclusion criteria: in the early-stages of dementia (MMSE score of 18 or above); if taking cholinesterase inhibitors, receiving a stable dose for 1 month prior to trial entry and with no intention to change the dose over the 9 month period of trial participation unless clinically indicated; availability of a family carer. Exclusion criteria: prior history of stroke, brain injury or other neurological condition; inability to speak English. Health technology: CR is an individualized approach for people with dementia (PwD) aimed at reducing functional disability, supporting self-management, and maximising engagement and social participation. PwD and their carers identify areas in which they would like to improve functioning and performance, and work together with a health professional (e.g. occupational therapist, psychologist) over a number of sessions to devise and implement strategies for addressing these personally-relevant goals. CR will be delivered in 10 individual sessions over 3 months, followed by 4 maintenance sessions over 6 months. There are no established alternative technologies. In the pilot (Am J Geriatr Psychiatry, 2010, DOI:10.1097/JGP.0b013e3181d579 2a) CR was compared with TAU and with an attention placebo condition (relaxation therapy). There was no evidence of a difference between the two control groups, so treatment as usual is an appropriate comparator. Sample size: Power calculations and attrition rates are based on the pilot trial. For the proposed study, intervention length has been increased in order to further strengthen effect sizes. To achieve 80% power to detect a medium effect size of 0.3, with alpha 0.05, in primary and secondary outcomes, 175 PwD need to complete the trial in each arm. Attrition was 20% at 6 months in the pilot, but is likely to be higher in a longer multi-centre trial; based on evidence from the recently-complete REMCARE trial, an attrition rate of 27% has been used. Therefore we will randomise 480 PwD, each with a family carer.

Related Research

Grants with similar aims, by meaning.

Cognitive Rehabilitation for Attention and Memory in people with Multiple Sclerosis (CRAMMS)
Specialist rehabilitation for people with Parkinson's disease in the community: an RCT
Evaluating the effectiveness and cost effectiveness of Dementia Care Mapping (DCM) to enable person-centred Care for people with dementia and their carers: A UK cluster randomised controlled trial in care homes (DCM EPIC trial)
Implementation of GREAT (Goal-oriented cognitive Rehabilitation in Early-stage Alzheimer’s and related dementias: a multi-centre single-blind randomised controlled Trial) in health services for people with dementia in Norway
Physical activity programmes for community dwelling people with mild to moderate dementia (DAPA - Dementia And Physical Activity)

Original classification

Research

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.